{
    "code": "52027356",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027356",
    "time": "2020-04-17 05:50:16",
    "許可證字號": "衛部藥輸字第027356號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/12\/25",
    "發證日期": "106\/12\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202735607",
    "中文品名": "澤珂&#174;膜衣錠250毫克",
    "英文品名": "ZYTIGA&#174; Film-Coated Tablets 250mg",
    "適應症": "ZYTIGA® 是一種CYP17 抑制劑，與prednisone 或prednisolone 併用，以治療\r\n(1)藥物或手術去勢抗性的轉移性前列腺癌，且在雄性素去除療法失敗後屬無症狀或輕度症狀而尚未需要使用化學治療(chemotherapy is not yet clinically indicated)者。\r\n(2)藥物或手術去勢抗性的轉移性前列腺癌且已接受過docetaxel 治療者。\r\n(3)新診斷具高風險的荷爾蒙敏感性轉移性前列腺癌的成年男性，且與雄性素去除療法併用。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新劑型",
    "監視期限": "",
    "主成分略述": "Abiraterone Acetate",
    "限制項目": "02輸　入 1L監視中新藥 1Q不得輸入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCA0024200  PATHEON INC. - TORONTO REGION OPERATIONS",
            "製造廠廠址": "2100 SYNTEX COURT, MISSISSAUGA, ONTARIO, CANADA, L5N 7K9",
            "製造廠公司地址": "",
            "製造廠國別": "CANADA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FIT0332000  JANSSEN-CILAG S.P.A.",
            "製造廠廠址": "VIA C. JANSSEN 04100 BORGO S. MICHELE-LATINA, ITALY",
            "製造廠公司地址": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE ITALY",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200093900",
            "成分名稱": "Abiraterone Acetate",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版] Zytiga FCT 250mg_USPI Sep2018+EUPI Nov2017(mHSPC)_v1901_0627(鴻)-108-07-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027356&Seq=003&Type=9"
        },
        {
            "title": "標籤 Zytiga FCT 250mg_label_v01_0109-107-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027356&Seq=002&Type=8"
        },
        {
            "title": "外盒 Zytiga FCT 250mg_box_v01_0109-107-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027356&Seq=001&Type=8"
        }
    ]
}